GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 203 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,302,665 | +117.3% | 33,813 | +1.9% | 0.02% | +122.2% |
| Q2 2022 | $1,059,845 | -11.1% | 33,172 | -3.6% | 0.01% | +12.5% |
| Q1 2022 | $1,191,720 | +87.6% | 34,403 | +58.5% | 0.01% | +60.0% |
| Q4 2021 | $635,335 | +14.9% | 21,706 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $553,069 | -27.2% | 21,706 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $760,144 | -38.1% | 21,706 | -9.7% | 0.01% | -58.8% |
| Q1 2020 | $1,228,561 | -39.1% | 24,047 | -5.3% | 0.02% | -19.0% |
| Q4 2019 | $2,018,251 | +63.8% | 25,390 | 0.0% | 0.02% | +50.0% |
| Q3 2019 | $1,231,923 | -4.1% | 25,390 | +3.9% | 0.01% | 0.0% |
| Q2 2019 | $1,285,122 | +5.1% | 24,432 | +5.8% | 0.01% | 0.0% |
| Q1 2019 | $1,222,524 | +28.9% | 23,097 | 0.0% | 0.01% | +16.7% |
| Q4 2018 | $948,132 | +8.0% | 23,097 | 0.0% | 0.01% | +33.3% |
| Q3 2018 | $877,686 | -15.9% | 23,097 | 0.0% | 0.01% | -25.0% |
| Q2 2018 | $1,044,000 | +23.0% | 23,097 | +31.4% | 0.01% | +20.0% |
| Q1 2018 | $849,000 | +22.7% | 17,581 | 0.0% | 0.01% | +25.0% |
| Q4 2017 | $692,000 | – | 17,581 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |